The worldwide societal costs of dementia: Estimates for 2009
- PMID: 20298969
- DOI: 10.1016/j.jalz.2010.01.010
The worldwide societal costs of dementia: Estimates for 2009
Abstract
Background: The purpose of this study was to update the previous estimate of the worldwide cost of dementia in 2005 to 2009.
Methods: The cost model is based on prevalence estimates, country and region-specific data on Gross Domestic Product per person and average wage, with results from previously published cost-of-illness studies in different countries. Prevalence figures are updated to 2009 and costs were adjusted to 2009 constant US dollars ($).
Results: The total worldwide societal cost of dementia, based on a dementia population of 34.4 million demented persons, was estimated to $422 billion in 2009, including $142 billion for informal care (34%).
Conclusions: The worldwide cost of dementia has increased by 34% (18% in fixed prices) between 2005 and 2009.
2010. Published by Elsevier Inc.
Similar articles
-
An estimate of the total worldwide societal costs of dementia in 2005.Alzheimers Dement. 2007 Apr;3(2):81-91. doi: 10.1016/j.jalz.2007.02.001. Alzheimers Dement. 2007. PMID: 19595921
-
An estimate of the worldwide prevalence and direct costs of dementia in 2003.Dement Geriatr Cogn Disord. 2006;21(3):175-81. doi: 10.1159/000090733. Epub 2006 Jan 9. Dement Geriatr Cogn Disord. 2006. PMID: 16401889
-
The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project.Int J Geriatr Psychiatry. 2011 Aug;26(8):825-32. doi: 10.1002/gps.2610. Epub 2010 Oct 28. Int J Geriatr Psychiatry. 2011. PMID: 21744385
-
Estimating the cost of epilepsy in Europe: a review with economic modeling.Epilepsia. 2007 Dec;48(12):2224-33. doi: 10.1111/j.1528-1167.2007.01251.x. Epilepsia. 2007. PMID: 18088267 Review.
-
The global economic burden of alcohol: a review and some suggestions.Drug Alcohol Rev. 2006 Nov;25(6):537-51. doi: 10.1080/09595230600944479. Drug Alcohol Rev. 2006. PMID: 17132572 Review.
Cited by
-
A quick test of cognitive speed (AQT): usefulness in dementia evaluations in primary care.Scand J Prim Health Care. 2013 Mar;31(1):13-9. doi: 10.3109/02813432.2012.751699. Epub 2013 Jan 7. Scand J Prim Health Care. 2013. PMID: 23293859 Free PMC article.
-
Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells.Drug Des Devel Ther. 2014 Dec 24;9:241-72. doi: 10.2147/DDDT.S71106. eCollection 2015. Drug Des Devel Ther. 2014. Retraction in: Drug Des Devel Ther. 2022 Nov 21;16:4041-4042. doi: 10.2147/DDDT.S397859. PMID: 25565776 Free PMC article. Retracted.
-
Effectiveness of family meetings for family caregivers on delaying time to nursing home placement of dementia patients: a randomized trial.PLoS One. 2012;7(8):e42145. doi: 10.1371/journal.pone.0042145. Epub 2012 Aug 2. PLoS One. 2012. PMID: 22876304 Free PMC article. Clinical Trial.
-
Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.J Cereb Blood Flow Metab. 2017 Jul;37(7):2396-2413. doi: 10.1177/0271678X16667364. Epub 2016 Jan 1. J Cereb Blood Flow Metab. 2017. PMID: 27596834 Free PMC article.
-
Children and young people's experience of parental dementia: A systematic review.Int J Geriatr Psychiatry. 2021 Jul;36(7):975-992. doi: 10.1002/gps.5542. Epub 2021 Apr 7. Int J Geriatr Psychiatry. 2021. PMID: 33826166 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical